|
[1]
|
Wang, X.H. and Mitch, W.E. (2014) Mechanisms of Muscle Wasting in Chronic Kidney Disease. Nature Reviews Nephrology, 10, 504-516. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gracia-Iguacel, C., Gonzalez-Parra, E., Perez-Gomez, M.V., Mahillo, I., Egido, J., Ortiz, A., et al. (2013) Prevalence of Protein-Energy Wasting Syndrome and Its Association with Mortality in Haemodialysis Patients in a Centre in Spain. Nefrologia, 33, 495-505.
|
|
[3]
|
Johansen, K.L., Shubert, T., Doyle, J., Soher, B., Sakkas, G.K. and Kent-Braun, J.A. (2003) Muscle Atrophy in Patients Receiving Hemodialysis: Effects on Muscle Strength, Muscle Quality, and Physical Function. Kidney International, 63, 291-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Rosenberg, I.H. (2011) Sarcopenia: Origins and Clinical Relevance. Clinics in Geriatric Medicine, 27, 337-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. (2010) Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39, 412-423. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyere, O., Cederholm, T., et al. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age Ageing, 48, 16-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Cruz-Jentoft, A.J. and Sayer, A.A. (2019) Sarcopenia. The Lancet, 393, 2636-2646. [Google Scholar] [CrossRef]
|
|
[8]
|
Fielding, R.A., Vellas, B., Evans, W.J., Bhasin, S., Morley, J.E., Newman, A.B., et al. (2011) Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. Journal of the American Medical Directors Association, 12, 249-256. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Gielen, E., O’Neill, T.W., Pye, S.R., Adams, J.E., Wu, F.C., Laurent, M.R., et al. (2015) Endocrine Determinants of Incident Sarcopenia in Middle-Aged and Elderly European Men. Journal of Cachexia, Sarcopenia and Muscle, 6, 242-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Souza, V.A., Oliveira, D., Barbosa, S.R., Correa, J., Colugnati, F.A.B., Mansur, H.N., et al. (2017) Sarcopenia in Patients with Chronic Kidney Disease Not Yet on Dialysis: Analysis of the Prevalence and Associated Factors. PLoS ONE, 12, e0176230. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lamarca, F., Carrero, J.J., Rodrigues, J., Bigogno, F.G., Fetter, R.L. and Avesani, C.M. (2014) Prevalence of Sarcopenia in Elderly Maintenance Hemodialysis Patients: The Impact of Different Diagnostic Criteria. The Journal of Nutrition, Health and Aging, 18, 710-717. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Kittiskulnam, P., Chertow, G.M., Carrero, J.J., Delgado, C., Kaysen, G.A. and Johansen, K.L. (2017) Sarcopenia and Its Individual Criteria Are Associated, in Part, with Mortality among Patients on Hemodialysis. Kidney International, 92, 238-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Murton, A.J., Constantin, D. and Greenhaff, P.L. (2008) The Involvement of the Ubiquitin Proteasome System in Human Skeletal Muscle Remodelling and Atrophy. Biochimica et Biophysica Acta, 1782, 730-743. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hershko, A. and Ciechanover, A. (1998) The Ubiquitin System. Annual Review of Biochemistry, 67, 425-479. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kisselev, A.F. and Goldberg, A.L. (2001) Proteasome Inhibitors: From Research Tools to Drug Candidates. Chemistry & Biology, 8, 739-758. [Google Scholar] [CrossRef]
|
|
[16]
|
Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., et al. (2001) Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science, 294, 1704-1708. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Thomas, S.S. and Mitch, W.E. (2013) Mechanisms Stimulating Muscle Wasting in Chronic Kidney Disease: The Roles of the Ubiquitin-Proteasome System and Myostatin. Clinical and Experimental Nephrology, 17, 174-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A. and Goldberg, A.L. (2001) Atrogin-1, a Muscle-Specific f-Box Protein Highly Expressed during Muscle Atrophy. Proceedings of the National Academy of Sciences of the United States of America, 98, 14440-14445. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., et al. (2004) Multiple Types of Skeletal Muscle Atrophy Involve a Common Program of Changes in Gene Expression. FASEB Journal, 18, 39-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Du, J., Wang, X., Miereles, C., Bailey, J.L., Debigare, R., Zheng, B., et al. (2004) Activation of caspase-3 Is an Initial Step Triggering Accelerated Muscle Proteolysis in Catabolic Conditions. Journal of Clinical Investigation, 113, 115-123. [Google Scholar] [CrossRef]
|
|
[21]
|
Workeneh, B.T., Rondon-Berrios, H., Zhang, L., Hu, Z., Ayehu, G., Ferrando, A., et al. (2006) Development of a Diagnostic Method for Detecting Increased Muscle Protein Degradation in Patients with Catabolic Conditions. Journal of the American Society of Nephrology, 17, 3233-3239. [Google Scholar] [CrossRef]
|
|
[22]
|
Wang, X.H., Zhang, L., Mitch, W.E., LeDoux, J.M., Hu, J. and Du, J. (2010) Caspase-3 Cleaves Specific 19 s Proteasome Subunits in Skeletal Muscle Stimulating Proteasome Activity. Journal of Biological Chemistry, 285, 21249-21257. [Google Scholar] [CrossRef]
|
|
[23]
|
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. and Kambadur, R. (2003) Myostatin Negatively Regulates Satellite Cell Activation and Self-Renewal. Journal of Cell Biology, 162, 1135-1147. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S.K., Sharma, M., et al. (2011) Myostatin Induces Degradation of Sarcomeric Proteins through a smad3 Signaling Mechanism during Skeletal Muscle Wasting. Molecular Endocrinology, 25, 1936-1949. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., et al. (2009) Smad2 and 3 Transcription Factors Control Muscle Mass in Adulthood. American Journal of Physiology-Cell Physiology, 296, C1248-C1257. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Enoki, Y., Watanabe, H., Arake, R., Sugimoto, R., Imafuku, T., Tominaga, Y., et al. (2016) Indoxyl Sulfate Potentiates Skeletal Muscle Atrophy by Inducing the Oxidative Stress-Mediated Expression of Myostatin and atrogin-1. Scientific Reports, 6, Article No. 32084. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zhang, L., Rajan, V., Lin, E., Hu, Z., Han, H.Q., Zhou, X., et al. (2011) Pharmacological Inhibition of Myostatin Suppresses Systemic Inflammation and Muscle Atrophy in Mice with Chronic Kidney Disease. The FASEB Journal, 25, 1653-1663. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Verzola, D., Procopio, V., Sofia, A., Villaggio, B., Tarroni, A., Bonanni, A., et al. (2011) Apoptosis and Myostatin mRNA Are Upregulated in the Skeletal Muscle of Patients with Chronic Kidney Disease. Kidney International, 79, 773-782. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Glass, D.J. (2010) Pi3 Kinase Regulation of Skeletal Muscle Hypertrophy and Atrophy. Current Topics in Microbiology and Immunology, 346, 267-278. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Zhang, L., Wang, X.H., Wang, H., Du, J. and Mitch, W.E. (2010) Satellite Cell Dysfunction and Impaired igf-1 Signaling Cause ckd-Induced Muscle Atrophy. Journal of the American Society of Nephrology, 21, 419-427. [Google Scholar] [CrossRef]
|
|
[31]
|
Stitt, T.N., Drujan, D., Clarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., et al. (2004) The igf-1/pi3k/akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting Foxo Transcription Factors. Molecular Cell, 14, 395-403. [Google Scholar] [CrossRef]
|
|
[32]
|
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., et al. (2004) Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy. Cell, 117, 399-412. [Google Scholar] [CrossRef]
|
|
[33]
|
Bailey, J.L., Zheng, B., Hu, Z., Price, S.R. and Mitch, W.E. (2006) Chronic Kidney Disease Causes Defects in Signaling through the Insulin Receptor Substrate/Phosphatidylinositol 3-Kinase/Akt Pathway: Implications for Muscle Atrophy. Journal of the American Society of Nephrology, 17, 1388-1394. [Google Scholar] [CrossRef]
|
|
[34]
|
Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., et al. (2009) Il-6 and Serum Amyloid a Synergy Mediates Angiotensin II-Induced Muscle Wasting. Journal of the American Society of Nephrology, 20, 604-612. [Google Scholar] [CrossRef]
|
|
[35]
|
Sriram, S., Subramanian, S., Sathiakumar, D., Venkatesh, R., Salerno, M.S., McFarlane, C.D., et al. (2011) Modulation of Reactive Oxygen Species in Skeletal Muscle by Myostatin Is Mediated through nf-Kappab. Aging Cell, 10, 931-948. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Powers, S.K., Kavazis, A.N. and DeRuisseau, K.C. (2005) Mechanisms of Disuse Muscle Atrophy: Role of Oxidative Stress. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 288, R337-R344. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Damiano, S., Muscariello, E., La Rosa, G., Di Maro, M., Mondola, P. and Santillo, M. (2019) Dual Role of Reactive Oxygen Species in Muscle Function: Can Antioxidant Dietary Supplements Counteract Age-Related Sarcopenia? International Journal of Molecular Sciences, 20, 3815. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Bratic, A. and Larsson, N.G. (2013) The Role of Mitochondria in Aging. Journal of Clinical Investigation, 123, 951-957. [Google Scholar] [CrossRef]
|
|
[39]
|
Zhang, L., Pan, J., Dong, Y., Tweardy, D.J., Dong, Y., Garibotto, G., et al. (2013) Stat3 Activation Links a c/ebpdelta to Myostatin Pathway to Stimulate Loss of Muscle Mass. Cell Metabolism, 18, 368-379. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
O’Sullivan, T.F., Smith, A.C. and Watson, E.L. (2018) Satellite Cell Function, Intramuscular Inflammation and Exercise in Chronic Kidney Disease. Clinical Kidney Journal, 11, 810-821. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Watanabe, H., Enoki, Y. and Maruyama, T. (2019) Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions. Biological and Pharmaceutical Bulletin, 42, 1437-1445. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Bastert, E. and Schlafke, D. (2011) Forensic Patients with Organic Brain Disorders. The World Journal of Biological Psychiatry, 12, 23-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wang, X.H., Hu, Z., Klein, J.D., Zhang, L., Fang, F. and Mitch, W.E. (2011) Decreased mir-29 Suppresses Myogenesis in CKD. Journal of the American Society of Nephrology, 22, 2068-2076. [Google Scholar] [CrossRef]
|
|
[44]
|
Ebner, N., Anker, S.D. and von Haehling, S. (2019) Recent Developments in the Field of Cachexia, Sarcopenia, and Muscle Wasting: Highlights from the 11th Cachexia Conference. Journal of Cachexia, Sarcopenia and Muscle, 10, 218-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
May, R.C., Kelly, R.A. and Mitch, W.E. (1987) Mechanisms for Defects in Muscle Protein Metabolism in Rats with Chronic Uremia. Influence of Metabolic Acidosis. Journal of Clinical Investigation, 79, 1099-1103. [Google Scholar] [CrossRef]
|
|
[46]
|
de Brito-Ashurst, I., Varagunam, M., Raftery, M.J. and Yaqoob, M.M. (2009) Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status. Journal of the American Society of Nephrology, 20, 2075-2084. [Google Scholar] [CrossRef]
|
|
[47]
|
Cohen, S., Nathan, J.A. and Goldberg, A.L. (2015) Muscle Wasting in Disease: Molecular Mechanisms and Promising Therapies. Nature Reviews Drug Discovery, 14, 58-74. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Haren, M.T., Siddiqui, A.M., Armbrecht, H.J., Kevorkian, R.T., Kim, M.J., Haas, M.J., et al. (2011) Testosterone Modulates Gene Expression Pathways Regulating Nutrient Accumulation, Glucose Metabolism and Protein Turnover in Mouse Skeletal Muscle. International Journal of Andrology, 34, 55-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Carrero, J.J., Qureshi, A.R., Nakashima, A., Arver, S., Parini, P., Lindholm, B., et al. (2011) Prevalence and Clinical Implications of Testosterone Deficiency in Men with End-Stage Renal Disease. Nephrology Dialysis Transplantation, 26, 184-190. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Rabkin, R., Sun, D.F., Chen, Y., Tan, J. and Schaefer, F. (2005) Growth Hormone Resistance in Uremia, a Role for Impaired Jak/Stat Signaling. Pediatric Nephrology, 20, 313-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Srinivas-Shankar, U., Roberts, S., Connolly, M.J., O’Connell, M.D., Adams, J.E., Oldham, J.A., et al. (2010) Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism, 95, 639-650. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Bhat, M., Kalam, R., Qadri, S.S., Madabushi, S. and Ismail, A. (2013) Vitamin D Deficiency-Induced Muscle Wasting Occurs through the Ubiquitin Proteasome Pathway and Is Partially Corrected by Calcium in Male Rats. Endocrinology, 154, 4018-4029. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Pfeifer, M., Begerow, B., Minne, H.W., Abrams, C., Nachtigall, D. and Hansen, C. (2000) Effects of a Short-Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women. Journal of Bone and Mineral Research, 15, 1113-1118. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Isoyama, N., Qureshi, A.R., Avesani, C.M., Lindholm, B., Barany, P., Heimburger, O., et al. (2014) Comparative Associations of Muscle Mass and Muscle Strength with Mortality in Dialysis Patients. Clinical Journal of the American Society of Nephrology, 9, 1720-1728. [Google Scholar] [CrossRef]
|
|
[55]
|
Chen, Y., Sood, S., Biada, J., Roth, R. and Rabkin, R. (2008) Increased Workload Fully Activates the Blunted irs-1/pi3-Kinase/Akt Signaling Pathway in Atrophied Uremic Muscle. Kidney International, 73, 848-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Sun, D.F., Chen, Y. and Rabkin, R. (2006) Work-Induced Changes in Skeletal Muscle igf-1 and Myostatin Gene Expression in Uremia. Kidney International, 70, 453-459. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Watson, E.L., Gould, D.W., Wilkinson, T.J., Xenophontos, S., Clarke, A.L., Vogt, B.P., et al. (2018) Twelve-Week Combined Resistance and Aerobic Training Confers Greater Benefits than Aerobic Training Alone in Nondialysis CKD. American Journal of Physiology-Renal Physiology, 314, F1188-F1196. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Kopple, J.D., Storer, T. and Casburi, R. (2005) Impaired Exercise Capacity and Exercise Training in Maintenance Hemodialysis Patients. Journal of Renal Nutrition, 15, 44-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Watson, E.L., Viana, J.L., Wimbury, D., Martin, N., Greening, N.J., Barratt, J., et al. (2017) The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease. Frontiers in Physiology, 8, Article No. 541. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Tamaki, M., Hagiwara, A., Miyashita, K., Wakino, S., Inoue, H., Fujii, K., et al. (2015) Improvement of Physical Decline through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6nx CKD Model Mice. Endocrinology, 156, 3638-3648. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Ko, G.J., Obi, Y., Tortorici, A.R. and Kalantar-Zadeh, K. (2017) Dietary Protein Intake and Chronic Kidney Disease. Current Opinion in Clinical Nutrition & Metabolic Care, 20, 77-85. [Google Scholar] [CrossRef]
|
|
[62]
|
Rhee, C.M., Ahmadi, S.F., Kovesdy, C.P. and Kalantar-Zadeh, K. (2018) Low-Protein Diet for Conservative Management of Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Controlled Trials. Journal of Cachexia, Sarcopenia and Muscle, 9, 235-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Maraj, M., Kusnierz-Cabala, B., Dumnicka, P., Gala-Bladzinska, A., Gawlik, K., Pawlica-Gosiewska, D., et al. (2018) Malnutrition, Inflammation, Atherosclerosis Syndrome (mia) and Diet Recommendations among End-Stage Renal Disease Patients Treated with Maintenance Hemodialysis. Nutrients, 10, 69. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Twycross-Lewis, R., Kilduff, L.P., Wang, G. and Pitsiladis, Y.P. (2016) The Effects of Creatine Supplementation on Thermoregulation and Physical (Cognitive) Performance: A Review and Future Prospects. Amino Acids, 48, 1843-1855. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Post, A., Tsikas, D. and Bakker, S.J.L. (2019) Creatine Is a Conditionally Essential Nutrient in Chronic Kidney Disease: A Hypothesis and Narrative Literature Review. Nutrients, 11, E1044. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Han, H.Q., Zhou, X., Mitch, W.E. and Goldberg, A.L. (2013) Myostatin/Activin Pathway Antagonism: Molecular Basis and Therapeutic Potential. The International Journal of Biochemistry & Cell Biology, 45, 2333-2347. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Jamart, C., Raymackers, J.M., Li, A.G., Deldicque, L. and Francaux, M. (2011) Prevention of Muscle Disuse Atrophy by mg132 Proteasome Inhibitor. Muscle Nerve, 43, 708-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Lang, C.H., Huber, D. and Frost, R.A. (2007) Burn-Induced Increase in Atrogin-1 and murf-1 in Skeletal Muscle Is Glucocorticoid Independent but Downregulated by igf-i. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 292, R328-R336. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Goldberg, A.L. (2012) Development of Proteasome Inhibitors as Research Tools and Cancer Drugs. Journal of Cell Biology, 199, 583-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Enrico, O., Gabriele, B., Nadia, C., Sara, G., Daniele, V., Giulia, C., et al. (2007) Unexpected Cardiotoxicity in Haematological Bortezomib Treated Patients. British Journal of Haematology, 138, 396-397. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Enoki, Y., Watanabe, H., Arake, R., Fujimura, R., Ishiodori, K., Imafuku, T., et al. (2017) Potential Therapeutic Interventions for Chronic Kidney Disease-Associated Sarcopenia via Indoxyl Sulfate-Induced Mitochondrial Dysfunction. Journal of Cachexia, Sarcopenia and Muscle, 8, 735-747. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Rupprecht, L., Mietlicki-Baase, E.G., Zimmer, D.J., McGrath, L.E., Olivos, D.R. and Hayes, M.R. (2013) Hindbrain glp-1 Receptor-Mediated Suppression of Food Intake Requires a pi3k-Dependent Decrease in Phosphorylation of Membrane-Bound AKT. American Journal of Physiology-Endocrinology and Metabolism, 305, E751-E759. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Hong, Y., Lee, J.H., Jeong, K.W., Choi, C.S. and Jun, H.S. (2019) Amelioration of Muscle Wasting by Glucagon-Like Peptide-1 Receptor Agonist in Muscle Atrophy. Journal of Cachexia, Sarcopenia and Muscle, 10, 903-918. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
McFarlane, C., Vajjala, A., Arigela, H., Lokireddy, S., Ge, X., Bonala, S., et al. (2014) Negative Auto-Regulation of Myostatin Expression Is Mediated by smad3 and Microrna-27. PLoS ONE, 9, e87687. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Wang, B., Zhang, C., Zhang, A., Cai, H., Price, S.R. and Wang, X.H. (2017) Microrna-23a and Microrna-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy. Journal of the American Society of Nephrology, 28, 2631-2640. [Google Scholar] [CrossRef]
|